PDR MEMBER LOGIN:
  • PDR Search

    Required field
  • PDR Drug Communications are designed to improve the speed and efficacy of the delivery of PDR Drug Alerts, Recalls and Approvals to physicians, prescribers, and their staff.

    Below are the PDR Drug Communications that have been issued by PDR Network. To view the communication details, click on the Medication name.

    If you have trouble accessing Alert details, click to get the latest version of the free Adobe Acrobat Reader software for your computer.

    Filter results by:

    Results 1-20 of 61

    July 01, 2015 Drug Alert: Important Drug Information

    ER/LA Opioid Analgesics

    Various

    June 29, 2015 Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION

    Symlin® (pramlintide acetate) injection

    AstraZeneca

    June 26, 2015 Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION

    Afrezza® (insulin human) Inhalation Powder

    sanofi-aventis U.S. LLC

    June 10, 2015 Drug Alert: Important Drug Warning

    Gilenya® (fingolimod)

    Novartis Pharmaceuticals Corporation

    June 03, 2015 Drug Alert: Important Prescribing Information

    VALCYTE® (valganciclovir)

    Genentech, Inc.

    March 13, 2015 Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION

    FARYDAK® (panobinostat)

    Novartis Pharmaceuticals Corporation

    January 28, 2015 Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION

    Afrezza® (insulin human) Inhalation Powder

    sanofi-aventis U.S. LLC

    November 10, 2014 Drug Alert: Important Drug Information

    Xeljanz® (tofacitinib)

    Pfizer, Inc.

    October 30, 2014 Drug Approval:

    HETLIOZ® (tasimelteon)

    Vanda Pharmaceuticals, Inc.

    September 24, 2014 Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION

    Trulicity™ (dulaglutide)

    Eli Lilly and Company

    September 03, 2014 Drug Alert: Important Drug Information

    ER/LA Opioid Analgesics

    Various

    August 13, 2014 Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION

    Afrezza® (insulin human) Inhalation Powder

    MannKind Corporation

    August 12, 2014 Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION

    Symlin® (pramlintide acetate) injection

    AstraZeneca

    May 13, 2014 Drug Alert: Important Drug Warning

    Xeljanz® (tofacitinib)

    Pfizer Inc

    April 14, 2014 Drug Alert: Important Prescribing Information

    JEVTANA® (cabazitaxel)

    sanofi-aventis U.S.

    March 31, 2014 Drug Approval:

    Aptiom® (eslicarbazepine acetate)

    Sunovion Pharmaceuticals

    March 24, 2014 Drug Alert: Important Drug Warning

    Zelboraf® (vemurafenib)

    Genentech

    February 14, 2014 Drug Alert: Important Drug Warning

    GAZYVA(TM) (obinutuzumab)

    Genentech

    February 13, 2014 Drug Approval:

    NEXAVAR® (sorafenib)

    Bayer

    Results 1-20 of 61